Pfizer submitted Emergency Use Authorization for novel COVID-19 oral antiviral candidate
On Nov. 16, 2021, Pfizer announced it had submitted an Emergency Use Authorization (EUA) of its investigational oral…
Pfizer’s COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis
On Nov. 5, 2021, Pfizer announced it was investigational novel COVID-19 oral antiviral candidate, PAXLOVID, significantly reduced hospitalization…
First case of SARS-CoV-2 in mink confirmed in Oregon
On Nov. 27, 2020, the U.S. Department of Agriculture (USDA) announced that it had confirmed cases of SARS-CoV-2…
White-tailed deer found to be huge reservoir of SARS-CoV-2 infection
On Nov. 8, 2020, research from the U.S. had shown that white-tailed deer were being infected with SARS-CoV-2,…
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
The FDA approved non-statin drug to treat high cholesterol
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
Karmanos Cancer Institute was awarded the President’s Trophy for second year in a row by McLaren Health Care
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
Karmanos Cancer Institute received the 2020 Women’s Choice Award
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
Biotechnology | Diagnostics | Life Science News | Neurology | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute established the McLaren Proton Therapy Center
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivors
On Sept. 24, 2019 Karmanos, Wayne State announced it had received a $3.1 million National Institutes of Health…
Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…
Biotechnology | Diagnostics | Life Science News | Neurology | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system
On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care system
On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grant
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Morey Cancer Center recognized by the American Society of Clinical Oncology with the QOPI Certification Program
On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…
Karmanos Cancer Institute began renovations to expand services in Farmington Hills
On May 18, 2018, The Barbara Ann Karmanos Cancer Institute announced it will expand its Lawrence and Idell…
The University of Michigan Cancer Center was renamed the Rogel Cancer Center
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
Francis Collins reappointed director of the U.S. National Institutes of Health
On Jun. 6, 2017, Francis S. Collins, M.D., Ph.D. was reappointed Director of the National Institutes of Health…
The CDC responded to the Flint, Michigan water crisis
On Jun. 24, 2016, the U.S. Centers for Disease Control and Prevention (CDC) released the results of its…
University of Michigan Board of Regents announced a $17.5 million commitment for cancer research from Madeline and Sidney Forbes
On Jun. 16, 2016, The University of Michigan Board of Regents announced a $17.5 million commitment for cancer…
Physio-Control was acquired by Stryker Corporation
On Apr. 5, 2016, Physio-Control was acquired by Michigan-based Stryker Corp. which acquired 100% of the stock of…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute joined McLaren Health Care
On Oct. 30, 2013, the Karmanos Cancer Institute and McLaren Health Care signed an agreement that created the…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Non-Profit Research | Oncology | Therapeutics
Karmanos researcher Patricia LoRusso appointed co-leader of the Stand Up To Cancer Dream Team
On Dec. 14, 2011, Patricia M. LoRusso, D.O., of the Barbara Ann Karmanos Cancer Institute in Detroit, Michigan;…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The Monroe Cancer Center opened
On Sept. 2, 2011, the Monroe Cancer Center opened as a joint venture between Karmanos Cancer Institute, Mercy…
Francis Collins appointed director of the U.S. National Institutes of Health
On Oct. 7, 2009, Francis S. Collins, M.D., Ph.D. was appointed the 16th Director of the National Institutes…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively for cancer patients
On Dec. 1, 2005, the Barbara Ann Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute acquired clinical facilities from the Detroit Medical Center
On May 1, 2005, The Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
Biotechnology | Diagnostics | Disease | Environmental | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
The National Center for Vermiculite and Asbestos-Related Cancers was established
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Institute and JP McCarthy Cord Stem Cell Bank founded
In 2001, The J.P. McCarthy Cord Stem Cell Bank at the Karmanos Cancer Institute was founded as a…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Non-Profit Research | Therapeutics
Human immunogenetics professor Dr. Gloria M. Dunston founded the National Human Genome Center at Howard University
In 2001, human immunogenetics professor Dr. Gloria M. Dunston founded the National Human Genome Center at Howard University….